Latest filing published 05 Mar 2019 for Evolent Health, Inc..
Filing timeline
BuySaleInsider track record
Nicholas McGrane: trading record in brief
All filings by Nicholas McGrane on record concern Evolent Health, Inc. The record holds 23 filings, for trades running from 1 March 2016 to 1 March 2019.
On the market, this insider has only sold: 11 sales, €2.0M in total. Outside the open market, there are 4 share grants and 8 option exercises.
The newest entry dates from 5 March 2019: a share grant, in Evolent Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nicholas McGrane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,098 shares0Class A Common StockSEC:0001628908-19-000010:0
- 22,401 shares0Class A Common StockSEC:0001628908-18-000005:0
- 1,667 shares@ US$3.840.2% of flowClass A Common StockSEC:0001628908-17-000036:0
- 1,667 shares@ US$25.421.6% of flowClass A Common StockSEC:0001628908-17-000036:1
- 1,667 shares@ US$3.840.2% of flowClass A Common StockSEC:0001628908-17-000032:0
- 1,567 shares@ US$24.531.5% of flowClass A Common StockSEC:0001628908-17-000032:1
- 100 shares@ US$25.400.1% of flowClass A Common StockSEC:0001628908-17-000032:2
- 495 shares@ US$25.750.5% of flowClass A Common StockSEC:0001643086-17-000004:0
- 10,000 shares@ US$3.841.5% of flowClass A Common StockSEC:0001643086-17-000004:1
- 10,000 shares@ US$27.0110.4% of flowClass A Common StockSEC:0001643086-17-000004:2
- 47,508 shares@ US$3.847.1% of flowClass A Common StockSEC:0000950157-17-000719:0
- 47,508 shares@ US$24.3045.2% of flowClass A Common StockSEC:0000950157-17-000719:1
- 1,667 shares@ US$3.840.3% of flowClass A Common StockSEC:0001643086-17-000003:0
- 1,667 shares@ US$24.281.6% of flowClass A Common StockSEC:0001643086-17-000003:1
- 1,667 shares@ US$3.840.3% of flowClass A Common StockSEC:0001643086-17-000002:0
- 1,667 shares@ US$22.521.5% of flowClass A Common StockSEC:0001643086-17-000002:1
- 5,001 shares@ US$3.840.8% of flowClass A Common StockSEC:0001643086-17-000001:0
- 5,001 shares@ US$22.504.5% of flowClsss A Common StockSEC:0001643086-17-000001:1
- 2,033 shares@ US$22.501.8% of flowClass A Common StockSEC:0001643086-17-000001:2
- 17,123 shares0Class A Common StockSEC:0000950157-17-000198:0
- 21,205 shares@ US$3.843.1% of flowClass A Common StockSEC:0000950157-16-002176:0
- 21,205 shares@ US$21.5417.7% of flowClass A Common StockSEC:0000950157-16-002176:1
- 12,902 shares0Class A Common StockSEC:0001140361-16-056449:0
23 of 23 declarations
